InstalabLoading...
InstalabLoading...
If you have ever had weight loss surgery, live with a digestive condition that impairs fat absorption, or carry chronic liver disease, your body may be struggling to hold on to one of the most essential nutrients in your diet. Vitamin A (retinol) supports everything from night vision to the lining of your gut, yet it never appears on a standard blood panel. By the time you notice symptoms like dry eyes, frequent infections, or difficulty seeing at night, your body's stores may already be severely depleted.
What makes this test particularly tricky to interpret is that your blood level of retinol is tightly controlled by your liver. Your liver hoards vitamin A and releases it into the bloodstream at a steady rate, so your number can look perfectly normal even as your reserves quietly shrink. It only drops below the threshold once your liver is running close to empty. That means a low result on this test is a late signal, not an early one, and it demands immediate attention.
Vitamin A exists in several forms. Retinol is the form that circulates in your blood, bound to a carrier protein called retinol binding protein (RBP4). Your cells convert retinol into retinal, which is essential for the light sensing pigments in your eyes, and into retinoic acid, which acts like a switch that turns genes on and off. Retinoic acid influences how your immune cells develop, how the lining of your gut and airways stays intact, and how your body repairs and renews tissue.
You cannot make vitamin A from scratch. It comes from two dietary sources: preformed vitamin A (retinyl esters) found in liver, dairy, eggs, and fish, and provitamin A carotenoids like beta carotene found in orange and green vegetables. Your intestine absorbs these and sends them to the liver, which stores roughly 90% of your total body supply. The liver then meters retinol into the bloodstream as needed.
The strongest outcome data connecting low serum retinol to a specific disease come from liver research. In a nationally representative U.S. study of over 12,000 adults from the NHANES III database, people with known risk factors for chronic liver disease who fell in the lowest fifth of serum retinol had dramatically higher rates of liver scarring compared to those in the highest fifth. The odds of likely liver fibrosis (a buildup of scar tissue in the liver measured by a scoring tool called FIB-4) were roughly 20 times higher in the lowest retinol group, and the risk of dying from liver related causes was nearly 8 times higher. These associations held after adjusting for demographics, body size, medical history, and dietary intake.
A separate cross sectional study of the Korean population found that while higher serum retinol was associated with having fatty liver disease (called NAFLD, or non alcoholic fatty liver disease), retinol deficiency within that group was linked to advanced fibrosis. An analysis of NHANES data in NAFLD patients found a U shaped relationship between serum retinol and death from any cause: both very low and very high levels carried elevated risk, with the lowest mortality in the middle range.
If your result is low and you have any risk factors for liver disease, the next step is a broader liver workup. Order ALT (alanine aminotransferase), AST (aspartate aminotransferase), and GGT (gamma glutamyl transferase) to check for active liver damage, and consider a FIB-4 score or imaging to assess fibrosis directly. A gastroenterologist or hepatologist can help determine whether the low retinol is a cause, a consequence, or both.
A 30 year prospective study following over 29,000 men found that those with higher serum retinol had significantly lower risk of dying from any cause, heart disease, and respiratory disease compared to men with the lowest levels. The reductions ranged from about 17% to 32% lower mortality risk across these categories. These associations persisted regardless of smoking intensity, alcohol use, body mass, or blood levels of other nutrients.
That said, supplementation trials tell a more cautious story. A meta analysis of 120 randomized trials involving over 1.6 million participants found that vitamin A supplements did not reduce all cause mortality in either children or adults when given broadly. In one large meta analysis of primary prevention trials, vitamin A supplementation was linked to a slight increase in cancer risk. The takeaway: low blood levels are clearly associated with worse outcomes, but swallowing extra pills when you are not deficient does not appear to help and may carry risk.
Vitamin A's role in vision is its oldest and best known function. Retinal, the active form used in the eye, is a structural component of rhodopsin, the light sensing pigment in your retinal rod cells. When retinol drops below a critical threshold, rod cells cannot regenerate rhodopsin fast enough, and you lose the ability to see in dim light. This is called night blindness, and it is one of the earliest functional signs of deficiency.
In more advanced cases, the surface of the eye dries out and develops characteristic white foamy patches called Bitot's spots. A case series from a U.S. tertiary eye center found that the most common causes of vitamin A deficiency retinopathy in developed countries were gastrointestinal surgery (especially bariatric procedures), liver disease, and poor diet. Prompt vitamin A replacement reversed many of the retinal changes, but in patients with longstanding deficiency, some structural damage to the retina persisted.
Retinoic acid directs how your immune cells behave, particularly in your gut. It helps T cells (a type of immune cell that coordinates your defense against pathogens) migrate to mucosal surfaces like the intestinal lining, and it promotes the development of regulatory T cells that keep inflammation in check. When vitamin A is low, mucosal barriers weaken, the balance between inflammatory and calming immune signals tips toward inflammation, and vaccine responses may be blunted.
In a study of 180 children with sepsis (a life threatening response to infection) admitted to intensive care, 62% were vitamin A deficient compared to 20% of healthy controls. Deficiency was associated with higher disease severity scores and longer ICU stays. In pediatric cancer patients undergoing chemotherapy, vitamin A deficiency at diagnosis was common (found in about 15% of patients at 18 months), although its direct impact on infection outcomes was less clear cut than that of other micronutrients like selenium.
Vitamin A requirements increase during pregnancy and breastfeeding. In a prospective cohort of nearly 500 mother newborn pairs in the Brazilian Amazon, women with vitamin A deficiency throughout pregnancy had a 39% higher risk of anemia at delivery. Their newborns also tended to weigh less, though this association weakened after accounting for iron status. Maternal and cord blood retinol levels in a Nigerian cohort were closely correlated, and lower levels in both were associated with poorer newborn growth and lower Apgar scores.
At the same time, too much preformed vitamin A in early pregnancy can cause birth defects by disrupting the gene regulation that guides organ formation in the embryo. This is why retinoid medications like isotretinoin are strictly contraindicated in pregnancy, and why high dose vitamin A supplements should be avoided unless prescribed for confirmed deficiency.
Vitamin A plays a less widely recognized role in how your body uses iron. A systematic review and meta analysis of 21 clinical trials found that vitamin A supplementation reduced the risk of anemia by 26% and raised hemoglobin levels compared to untreated groups, regardless of age or life stage. In pregnant and breastfeeding women specifically, supplementation significantly increased ferritin (a measure of iron stores). The mechanism appears to involve vitamin A helping to mobilize iron from storage in the liver and supporting the production of new red blood cells.
Serum retinol is measured by a technique called HPLC (high performance liquid chromatography). The WHO endorsed deficiency cutpoint of less than 0.70 µmol/L (approximately 20 µg/dL) was established primarily in children but is widely applied to adults. Typical adult lab reference ranges run from about 28 to 86 µg/dL (1.0 to 3.0 µmol/L). No major guideline body has defined an "optimal" range for longevity or chronic disease prevention beyond meeting normal intake and avoiding both deficiency and excess.
| Status | Serum Retinol | What It Suggests |
|---|---|---|
| Deficient | Below 20 µg/dL (below 0.70 µmol/L) | Liver stores are severely depleted. Immediate investigation and repletion are warranted. |
| Low/Marginal | 20 to 28 µg/dL (0.70 to 1.0 µmol/L) | Stores may be suboptimal, especially if inflammation is present. Retest with CRP. |
| Normal | 28 to 86 µg/dL (1.0 to 3.0 µmol/L) | Adequate liver reserves in the absence of active inflammation. |
| Elevated | Above 86 µg/dL (above 3.0 µmol/L) | Possible chronic excess. Consider supplement and dietary retinol review. |
These ranges are orientation, not rigid targets. Your lab may use slightly different cutpoints. Because retinol is homeostatically buffered, a value in the normal range does not guarantee your stores are robust, and a value just below normal during an acute illness may reflect inflammation rather than true depletion. Always compare results within the same lab over time.
The single biggest confounder for this test is inflammation. Retinol binding protein, the carrier that transports retinol in your blood, is what scientists call a negative acute phase reactant: it drops during any inflammatory state. A meta analysis of 15 studies found that subclinical infection lowered plasma retinol by 13% during the incubation phase of illness, 24% during early recovery, and 11% during late recovery, even in people with adequate liver stores. If you have an active infection, recent surgery, or elevated CRP (C reactive protein, a general inflammation marker), your retinol result may appear falsely low.
Because serum retinol is so tightly controlled by your liver and so easily distorted by inflammation, a single reading tells you less than most blood tests. A normal result does not prove your stores are full, and a low result during illness may not mean you are truly deficient. The most useful approach is to get a baseline when you are healthy, then retest in 3 to 6 months if you are making dietary changes, starting supplementation, or recovering from a condition that depletes stores.
For people at ongoing risk (after bariatric surgery, with chronic liver disease, Crohn's disease, or celiac disease), testing every 6 to 12 months is reasonable. Always pair the test with a CRP measurement so you can tell whether a low result reflects true depletion or just an inflammatory dip. If your retinol is below 20 µg/dL on two separate draws taken when CRP is normal, that is a reliable signal of deficiency.
A confirmed low result should trigger a two pronged response: figure out why it is low, and start repletion. The most common causes in developed countries are malabsorption (from bariatric surgery, celiac disease, Crohn's disease, or pancreatic insufficiency) and liver disease. Order a CRP and AGP (alpha 1 acid glycoprotein) if not already done, along with a basic liver panel. If malabsorption is suspected, check other fat soluble vitamins (D, E, K) because they are absorbed through the same pathway and often drop together.
For repletion, your physician will typically prescribe oral vitamin A, with the dose and duration depending on severity. In severe deficiency with eye symptoms, higher doses are used initially. Retesting in 2 to 3 months confirms whether stores are recovering. If you have a very high result along with a history of heavy supplement use or liver disease, an evaluation for vitamin A toxicity is appropriate, as chronic excess can cause liver damage.
Evidence-backed interventions that affect your tTG IgG level
tTG IgG is best interpreted alongside these tests.